Hemoconcentrators, also referred to as hemofilters or
ultrafiltration devices, which contain a semipermeable membrane that allows
passage of water and electrolytes out of the blood. They are used in lieu of
diuretics to remove excess fluid or electrolytes and to raise the hematocrit of
the perfusate. Hemoconcentrators can be connected to the cardiopulmonary bypass
circuit (CPB) in different configurations. Blood can be drawn from the venous
line, the arterial line, or the systemic flow line, and the filtered blood may
be transferred through the venous line or the cardiotomy or venous reservoirs.
However, when blood is drawn from the high pressure line (e.g. systemic flow
line), a pump is required to propel the blood through the device. Removal of
fluid can be up to 180ml/min (at a flow of 500ml/min); however, it is often in
the range of 30 ml/min to 50 ml/min.
Strong expertise with attention to detail
makes our market research reports stand apart, Request a Report sample @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34430
Hemoconcentrators
can be used after CPB to concentrate the pumped blood before it is transferred
back to the patient either through a bag or directly through the patient’s
venous line. Unlike cell savers, hemoconcentrators conserve platelets, albumin,
and coagulation factors. However, hemoconcentrated blood contains heparin which
is required to be neutralized with the help of protamine before infusion.
Hemoconcentrators can be easily controlled and do not cause excessive loss of
potassium.
The global
adult and pediatric hemoconcentrators market is undergoing a significant
growth due to the increase in prevalence of cardiac diseases requiring
intensive treatment, rise in geriatric population, and technological
advancements in fluid management. It is also developing rapidly owing to the participation
of several new players in the market. The new entrants are focusing on new
technologies and launching of new products in the market. According to the WHO,
cardiovascular diseases are the leading cause of death across the world. Around
17.5 million people died due to cardiovascular diseases in 2012. Out of these,
more than 7.4 million deaths were caused by coronary heart diseases and 6.7
million by stroke. The escalating number of people suffering from
cardiovascular diseases is expected to augment the adult and pediatric
hemoconcentrators market in the near future. The adult and pediatric
hemoconcentrators market can be segmented based on type, end-user, and region.
On the basis of type, the market can be further classified into adult hemoconcentrators
and pediatric hemoconcentrators. By end-user, the market can be divided into
hospitals, ambulatory surgical centers, and others.
Pre Book Adult and Pediatric Hemoconcentrators Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=34430<ype=S
Geographically, the adult and pediatric hemoconcentrators market
can been categorized into North America, Europe, Asia Pacific, Latin America,
and Middle East & Africa. North America accounts for the largest share of
the adult and pediatric hemoconcentrators market due to the high adoption rate
of technologically enhanced instruments, increase in cell-based research activities,
rise in disposable income, and advanced healthcare infrastructure in the
region. Europe accounts for the second largest market, in terms of revenue,
owing to the significant investments in healthcare and rise in geriatric
population. Asia Pacific is expected to expand at high CAGR during the forecast
period due to the increase in prevalence of cardiovascular diseases in the
region. According to the Organisation for Economic Co-operation and Development
(OECD), cardiovascular diseases are the leading cause of death in Asia Pacific;
although they are preventable. Cardiovascular diseases caused an estimated 9.3
million deaths in the region and accounted for about one-third of the total
deaths in 2012. Latin America and Middle East & Africa are expected to be
the prospective markets in the near future for adult and pediatric
hemoconcentrators due to the high adoption rate of precise analytical
instruments and the rapidly developing pharmaceutical and biotechnology
industry.
Request COVID Analysis on Adult and Pediatric Hemoconcentrators Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=34430
Some of the key players operating in adult and pediatric
hemoconcentrators market are Medtronic, ANDOCOR n.v., Terumo Cardiovascular
Systems Corporation, Sorin Group, MEDIVATORS Inc., and MAQUET Holding B.V.
& Co. KG.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to industry leaders, consultants, and
strategy professionals.
Our reports are single-point solutions for industries to grow, evolve,
and mature. Our significant-time data collection methods along with ability to
track more than one million high growth niche products are aligned with your
aims. The detailed and proprietary statistical models used by our analysts
offer insights for making right decision in the shortest span of time. For
organizations that require specific but comprehensive information we offer
customized solutions through adhoc reports. These demands are delivered with
the perfect combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for client-specific problems
with right methodology of research is the key to help enterprises reach right
decision.
U.S. Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
